生物
血清学
病毒学
抗原
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
2019-20冠状病毒爆发
免疫学
2019年冠状病毒病(COVID-19)
抗体
医学
疾病
爆发
病理
传染病(医学专业)
作者
Samuel Wilks,Barbara Mühlemann,Xiaoying Shen,Sina Türeli,Eric B. LeGresley,Antonia Netzl,Miguela A. Caniza,Jesus N. Chacaltana-Huarcaya,Victor M. Corman,Xiaoju Daniell,Michael Datto,Fatimah S. Dawood,Thomas N. Denny,Christian Drosten,Ron A. M. Fouchier,Patricia García,Peter Halfmann,Agatha N. Jassem,Lara M. Jeworowski,Terry C. Jones
出处
期刊:Science
[American Association for the Advancement of Science]
日期:2023-10-06
卷期号:382 (6666): eadj0070-eadj0070
被引量:133
标识
DOI:10.1126/science.adj0070
摘要
During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, multiple variants escaping preexisting immunity emerged, causing reinfections of previously exposed individuals. Here, we used antigenic cartography to analyze patterns of cross-reactivity among 21 variants and 15 groups of human sera obtained after primary infection with 10 different variants or after messenger RNA (mRNA)-1273 or mRNA-1273.351 vaccination. We found antigenic differences among pre-Omicron variants caused by substitutions at spike-protein positions 417, 452, 484, and 501. Quantifying changes in response breadth over time and with additional vaccine doses, our results show the largest increase between 4 weeks and >3 months after a second dose. We found changes in immunodominance of different spike regions, depending on the variant an individual was first exposed to, with implications for variant risk assessment and vaccine-strain selection.
科研通智能强力驱动
Strongly Powered by AbleSci AI